Deficient Aseptic Filling And Freeze Drying Hamstring Sandoz’s US Herceptin

FDA Trastuzumab Filing First Submitted In December 2021; EMA Filing Also Pending

Sandoz spoke to Generics Bulletin in the wake of confirming a recent complete response letter for its partnered biosimilar Herceptin candidate in the US.

Sandoz logo on building
• Source: Shutterstock

More from Biosimilars

More from Products